ANEUVO secures $22M Series C funding to strengthen ExaStim

ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, announced the closing of a Series C funding round...

Cognito Therapeutics raises $105M for Alzheimer’s therapeutic advancement

Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer’s disease therapeutic. The Massachusetts-based company’s oversubscribed Series C financing...

Science Corporation closes $230M Series C to support BCI tech

Science Corporation announced that it closed an oversubscribed $230 million Series C financing round. Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital,...

Polares Medical raises $50M for heart leaflet replacement system

Polares Medical announced that it closed a $50 million Series C financing round to support its heart leaflet replacement system. Lausanne, Switzerland-based Polares designed its...

Xsensio raises $7M for continuous biosensing tech

Xsensio announced that it closed a $7 million oversubscribed Series A financing round to support its patient monitoring technology. The Lausanne, Switzerland-based company develops technology...

RAYDIAX secures €7.5M for first-in-human studies and market entry of CT “TACT”

RAYDIAX, a spin-off of the STIMULATE research campus/Otto-von-Guericke-University Magdeburg, has secured €7.5 million for first-in-human studies and the market entry of its therapy assistance...

CrannMed secures €12.5M in EIC funds for new pain relief device

Galway medical device manufacturer CrannMed has qualified for a €12.5m accelerator grant from the European Innovation Council (EIC) to develop a chronic inflammatory pain...

Blue Arbor adds $5M in Ottobock partnership to advance neuromuscular interface

Blue Arbor Technologies announced a partnership with Ottobock, anchored by a $5 million investment. The investment positions Ottobock — also the leading shareholder in Onward...

Trinity Biotech raises $25M to advance CGM+ system

Trinity Biotech announced that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors...

Latest articles